CHMP recommends Celltrion’s Regkirona® regdanvimab for COVID-19

Nov 12, 2021

The CHMP recommended approval of Celltrion’s Regkirona® regdanvimab for the treatment of adults with COVID-19 who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19.

Print Page Mail Article